Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Axsome Therapeutics logo in transparent PNG and vectorized SVG formats
In this photo illustration, the Axsome Therapeutics logo is displayed ...
Axsome Therapeutics Wins FDA Nod for Auvelity in Alzheimer’s Agitation ...
Why Did Axsome Therapeutics Stock Hit Another Record High Today? - AOL
Axsome Therapeutics to Participate in Upcoming Investor Conferences ...
Axsome Therapeutics Reports First Quarter 2026 Financial Results and ...
Axsome Therapeutics Clocks Better Than Expected Q1 Sales, Depression ...
Axsome therapeutics hi-res stock photography and images - Alamy
U.S. FDA Approves Axsome Therapeutics’ SYMBRAVO™ (meloxicam and ...
About Axsome - Axsome Therapeutics
Axsome Therapeutics Announces FDA Acceptance and Priority Review of ...
Axsome Therapeutics Announces AXS-05 Achieves Primary
Axsome Therapeutics Announces FDA… | American Headache Society
Axsome Therapeutics wins FDA for novel antidepressant Auvelity
Axsome Therapeutics (NASDAQ:AXSM) Stock Price News
Axsome Therapeutics, Inc. on LinkedIn: Today, Axsome was honored to ...
Axsome Therapeutics announces selling of common stock in a public ...
Axsome (AXSM) Down on Public Offering of Common Stock
Axsome Therapeutics Emerges as a High-Growth Contender in Neurological ...
Axsome Therapeutics Jobs | Levels.fyi
Axsome Therapeutics Jumps On FDA Priority Review For Alzheimer's ...
Axsome Therapeutics Careers | Levels.fyi
Axsome Therapeutics CEO buys, sells shares in October 2025 trades.
Is Axsome Therapeutics Positioned to Lead the Neuroscience Revolution ...
Axsome Launches Surging Phase 3 Trial for Fibromyalgia Drug
Axsome Therapeutics: A Conditional Buy Built On SG&A Discipline (NASDAQ ...
Axsome Therapeutics: Is It Time to Ride the Momentum?
Axsome Therapeutics Champions Mental Health During Awareness Week ...
Axsome to Submit New Drug Application for Narcolepsy Treatment AXS-12 ...
Axsome Therapeutics: Neuroscience Innovator Captures Market Attention
Axsome Therapeutics, Inc. on LinkedIn: We are excited to present new ...
Axsome Therapeutics: Reviewing Q1 Financials, Pipeline Updates (NASDAQ ...
Axsome to Submit Narcolepsy Drug Candidate AXS-12 to FDA in 2025’s ...
Fame | Axsome Therapeutics net worth and salary income estimation Dec ...
Axsome Therapeutics, Inc. on LinkedIn: Axsome Therapeutics Voices its ...
Axsome Stock's Strong Growth And Expanding Pipeline: Why I Assign A Buy ...
Axsome Therapeutics: Navigating New Heights?
Axsome Therapeutics Shares Dip Following CEO's Stock Disposal ...
Axsome Therapeutics stock jumps after FDA grants priority review for ...
Axsome wins FDA priority review for Auvelity in Alzheimer’s disease ...
Axsome Phase III program of AXS-05 in Alzheimer’s disease agitation ...
Axsome Therapeutics Announces FDA Approval of AUVELITY(TM)
Axsome Therapeutics, Inc. on LinkedIn: #mentalhealthmonth
Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 ...
Axsome Therapeutics Files S-1 with the US SEC
Axsome Therapeutics $7.75M Securities Lawsuit Settlement
Axsome Therapeutics (AXSM) Q4 2024 Earnings: Auvelity Sales Soar | Monexa
Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $7,121,346.68 in Stock
Axsome Therapeutics begins Phase III study on AXS-14 for fibromyalgia
Axsome Therapeutics, Inc. on LinkedIn: Axsome is excited to be ...
Axsome Therapeutics Unveils Mixed Results In ADHD Treatment. Axsome ...
Axsome Therapeutics Receives FDA Priority Review for AXS-05 in ...
Axsome Therapeutics: A Neuroscience Leader with a Strong Growth and ...
Axsome Therapeutics, Inc. on LinkedIn: Axsome Therapeutics Supports the ...
Axsome Therapeutics Q3 2025 slides: Strong revenue growth amid pipeline ...
Axsome (AXSM) Starts Late-Stage Study of Migraine Drug AXS-07
Axsome Therapeutics: Navigating a Crossroads of Growth and Uncertainty ...
What is Sales and Marketing Strategy of Axsome Therapeutics Company ...
Axsome Therapeutics, Inc. on LinkedIn: Axsome Therapeutics and the ...
Axsome Therapeutics launches antidepressant in crowded market, route to ...
Axsome Therapeutics Inc. (AXSM) Soars 8.02% – Canada News Group
Axsome is pleased to be one of Fast Company’s 2023 Most Innovative ...
Axsome CRESCENDO Survey is Important Step Forward in Raising Awareness ...
Axsome Therapeutics, Inc. on LinkedIn: #aanam
Axsome Therapeutics, Inc. on LinkedIn: Join us at the American Academy ...
Axsome Therapeutics Shares Drop Following 'Disappointing' Drug Trial ...
Axsome Therapeutics, Inc. on LinkedIn: We are pleased to announce the ...
Axsome Offers Updates on Sunosi and AXS-12 | Sleep Review
What are Mission Vision & Core Values of Axsome Company? – Pestel ...
Axsome Therapeutics Stock Soars on Teva Settlement and FDA Approval
Why Axsome Therapeutics, Inc. (AXSM) is the Best Performing Pharma ...
Axsome Therapeutics, Inc. on LinkedIn: #ascp2024
Axsome Therapeutics, Inc. on LinkedIn: We are honored to be a ...
Axsome Therapeutics, Inc. on LinkedIn: #alzheimersawarenessmonth
Axsome Presents Q1 Results, Advances in Sleep Medicine Pipeline | Sleep ...
Axsome Q2 Revenue Surges 72% to $150M as AUVELITY Sales Jump 84% | AXSM ...
Axsome to Present Positive Phase 3 AXS-05 & AXS-12 Results at AAN 2025
Axsome Therapeutics, Inc. on LinkedIn: Axsome is pleased to participate ...
Axsome Therapeutics Jobs & Careers - 2 Open Positions | Glassdoor
Axsome Therapeutics, Inc. | LinkedIn
Axsome Therapeutics, Inc. on LinkedIn: #stopthestigma #mentalhealth #dyk
FDA refuses Axsome filing for former Pfizer fibromyalgia asset
Axsome Therapeutics, Inc. (AXSM) Q1 2019 Earnings Call Transcript | The ...
Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for ...
Homepage - Axsome Therapeutics
Careers - Axsome Therapeutics
Axsome Therapeutics (AXSM) Company Profile, History, Products & Services
Axsome Therapeutics (AXSM) Company Profile & Description
Axsome Therapeutics Company Profile - Office Locations, Competitors ...
Axsome Therapeutics to Report First Quarter 2021 Financial Results on ...
Axsome Therapeutics Inc Company Profile - Axsome Therapeutics Inc ...
Axsome Therapeutics Inc Company Profile - GlobalData
FDA Approves Axsome Therapeutics’ Symbravo for Migraine with or without ...
AXSM Stock In Spotlight Ahead Of Key FDA Verdict On Alzheimer’s Drug ...
FDA Approves AUVELITY for Alzheimer's Disease Agitation Treatment
Allegiant Q1 adjusted EPS jumps 79% to $3.77 | ALGT Stock News
Axsome’s AXS-05 challenges current standard of care for Alzheimer’s ...
Webinar: Solving the Residual Sleepiness Puzzle in OSA Patients
Axsome’s Unexpected Leap: Analyzing Market Dynamics
7 Small-Cap Growth Stocks With 1,000% Upside Potential
Axsome's Auvelity: A New Therapy For Major Depressive Disorder (NASDAQ ...
Is It Too Late to Buy Axsome?
